Clin2
NCT06612554Possibly a fitRecruiting

Zinc supplements for HIV patients with low CD4 counts

HIVZinc StatusHIV Infection

Part of Immune system & allergy, Infections clinical trials.

This trial tests whether taking zinc supplements helps HIV patients who have low CD4 cell counts even when their virus is well-controlled. If your zinc levels are normal but your immune cells are slow to recover, this might be for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must have confirmed HIV infection.
  • You must be 18 years old or older.
  • Your blood zinc level must be less than 150 micrograms per deciliter.
  • You must be on a stable HIV medication regimen for at least 3 months and have taken it for at least 6 months total.
  • Your HIV viral load must be undetectable (under 50 copies per mL), though brief minor rises are okay.
  • Your CD4 count must be consistently below 500 cells per cubic millimeter, or have increased by less than 80 cells after a year of undetectable virus.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07216794Recruiting· Phase 2
Alendronate trial to reduce hidden HIV

This study tests if alendronate, a bone-strengthening medicine, can shrink the reservoir of HIV that stays in your body even when on treatment. You must have well-controlled HIV on antiretroviral therapy for at least one year but no more than ten years, and meet specific health requirements.

San Francisco, California
NCT06434753Recruiting· Phase 3
Zinc supplements for stable advanced liver disease

This trial tests whether taking zinc supplements can improve the outlook for people with a certain type of advanced liver disease that is still stable (no major complications). If you have compensated advanced chronic liver disease and meet the criteria, you might be able to join.

Barcelona
NCT07367412Recruiting
Zinc supplements for infection prevention in older hospital patients

This study tests whether giving zinc supplements to older patients (65+) in the hospital can help prevent infections. It is for patients at Herlev Hospital who are not already taking high doses of zinc or receiving certain specialized treatments.

Herlev, Copenhagen
NCT05835037Recruiting· Phase 4
Zinc supplement study for prediabetes blood sugar control

This study tests whether taking zinc can improve how your body controls blood sugar in people with prediabetes. It may help slow the progression toward type 2 diabetes, but you would need to meet specific health and medication criteria.

Lancaster, Pennsylvania
NCT07698548Not yet recruiting
Herbal medicine plus HIV treatment for low CD4

This trial tests if adding a Chinese herbal medicine (Fuyang Jiedu Granules) to your regular HIV treatment can help raise your CD4 count. It's for people whose CD4 count stays low even after years of successful HIV treatment.

Beijing, Beijing Municipality
NCT07793695Not yet recruiting· Phase 2
Zinc supplement with immunotherapy for advanced liver cancer

This study tests different doses of zinc supplements combined with standard targeted therapy and immunotherapy for advanced liver cancer.

Hefei, Anhui

Hear when a new HIV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.